We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. When reviewing indications for long-term PPI therapy, ...
This study was presented at the American College of Chest Physicians meeting in Pittsburgh (PA, USA) in October 2011. The study objective was to evaluate the association of proton pump inhibitors ...
A new practice guideline aims to help clinicians make decisions about when and how to safely deprescribe proton pump inhibitors (PPIs). The evidence-based recommendations incorporate data from key ...
Omeprazole, a proton pump inhibitor (PPI), protects patients on dual antiplatelet therapy (DAPT) against gastrointestinal events regardless of whether their regimen involves low-dose or high-dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results